| Dr Brett Chris Furutani, PHARMD | |
|
555 Kilauea Ave, Hilo, HI 96720-3011 | |
| (808) 935-9075 | |
| Not Available |
| Full Name | Dr Brett Chris Furutani |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 555 Kilauea Ave, Hilo, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821233800 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 2798 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett Chris Furutani, PHARMD 1810 Haleokea St, Hilo, HI 96720-5947 Ph: (808) 959-6456 | Dr Brett Chris Furutani, PHARMD 555 Kilauea Ave, Hilo, HI 96720-3011 Ph: (808) 935-9075 |
News Archive
MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.
MicroPhage announced that it has submitted human data from a pivotal clinical study of its ‘Microphage MRSA/MSSA Blood Culture Test' to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage's instrument-free, rapid tests is based on the Company's patented Bacteriophage Amplification platform technology. MicroPhage further announced that it has already begun OUS commercial shipments of the test.
While both presidential candidates have served up proposals to ease voter angst about the affordability of health care, neither candidate tackles the core issue of controlling health care cost growth, according to an article by economist Paul B. Ginsburg, Ph.D., in the Oct. 14 New England Journal of Medicine.
Unigene Laboratories, Inc. (http://www.unigene.com) announced today that it has selected a lead peptide compound, designated UGP281, from its obesity program for development.
A major Nordic research project involving researchers from the University of Copenhagen has, for the first time ever, mapped the use of alternative treatment among multiple sclerosis patients - knowledge which is important for patients with chronic disease and the way in which society meets them.
› Verified 5 days ago
Melissa Hashimoto, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Aupuni St Ste 115, Hilo, HI 96720 Phone: 808-393-9293 | |
Ken Everly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 E Makaala St, Hilo, HI 96720 Phone: 808-961-1001 | |
Jody Yamada-ueda, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 78 Mokihana St, Hilo, HI 96720 Phone: 808-747-1457 | |
Kenneth Ooka, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 Ponahawai St Ste 206, Hilo, HI 96720 Phone: 808-333-3420 | |
Lauren Domingo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 E Puainako St, Hilo, HI 96720 Phone: 808-959-8700 | |
Mrs. Michele Mari Yonemori, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 333 Kilauea Ave, Hilo, HI 96720 Phone: 808-935-0001 Fax: 808-969-9833 | |
Dr. Anita Ciarleglio, PH.D. RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1178 Kinoole St, Hilo, HI 96720 Phone: 808-276-9231 Fax: 808-961-4795 |